T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Keurig Dr Pepper
KDP
$40.2B
| $47.2M | 0.01% |
488,290
+1,435
| +0.3% | +$132K |
|
802
eBay
EBAY
$45.5B
| $47.1M | 0.01% |
2,012,395
-10,662
| -0.5% | -$257K |
|
803
PACCAR
PCAR
$69B
| $47M | 0.01% |
1,359,888
+6,426
| +0.5% | +$236K |
|
|
CIR
804
DELISTED
CIRCOR International, Inc
CIR
| $46.9M | 0.01% |
822,500
-3,200
| -0.4% | -$172K |
|
|
PPL
805
PPL Corp
PPL
$26.7B
| $46.5M | 0.01% |
1,232,472
-3,400
| -0.3% | -$129K |
|
|
PCH
806
DELISTED
PotlatchDeltic
PCH
| $46.4M | 0.01% |
1,361,590
-10,400
| -0.8% | -$352K |
|
807
CDW
CDW
$17.1B
| $46.3M | 0.01% |
1,154,406
+1,105,533
| +2,262% | +$45.9M |
|
808
Trimble
TRMB
$13.1B
| $46.2M | 0.01% |
1,895,741
-1,223,459
| -39% | -$30.6M |
|
809
Cohen & Steers
CNS
$4.36B
| $46.2M | 0.01% |
1,141,670
-3,970
| -0.3% | -$156K |
|
810
Church & Dwight Co
CHD
$24B
| $46.1M | 0.01% |
896,588
+980
| +0.1% | +$47.3K |
|
811
Wheaton Precious Metals
WPM
$61.3B
| $46.1M | 0.01% |
1,958,216
-2,059,350
| -51% | -$39.7M |
|
812
Paychex
PAYX
$42.8B
| $45.8M | 0.01% |
769,593
-2,220
| -0.3% | -$119K |
|
813
TransDigm Group
TDG
$68.3B
| $45.7M | 0.01% |
173,490
+74,214
| +75% | +$18.1M |
|
|
AVXS
814
DELISTED
AveXis, Inc. Common Stock
AVXS
| $45.6M | 0.01% |
1,246,720
-7,200
| -0.6% | -$243K |
|
|
SP
815
DELISTED
SP Plus Corporation
SP
| $45.6M | 0.01% |
2,018,620
+30,590
| +2% | +$687K |
|
816
Veeco
VECO
$3.26B
| $45.5M | 0.01% |
2,749,620
-1,132,062
| -29% | -$20.1M |
|
817
Ethan Allen Interiors
ETD
$575M
| $45.4M | 0.01% |
1,373,120
-53,600
| -4% | -$1.73M |
|
818
MarketAxess Holdings
MKTX
$5.72B
| $45.3M | 0.01% |
311,846
+17,406
| +6% | +$2.31M |
|
819
Barclays
BCS
$94.4B
| $45.2M | 0.01% |
6,348,194
-6,661,963
| -51% | -$59.9M |
|
820
Quanex
NX
$1B
| $45M | 0.01% |
2,422,040
+169,700
| +8% | +$3.17M |
|
821
Masco
MAS
$14.7B
| $45M | 0.01% |
1,453,786
-15,192
| -1% | -$479K |
|
|
BUFF
822
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $45M | 0.01% |
1,926,538
+3,400
| +0.2% | +$84.5K |
|
|
CLR
823
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $44.9M | 0.01% |
992,864
-30,357
| -3% | -$1.19M |
|
|
KMG
824
DELISTED
KMG Chemicals Inc
KMG
| $44.9M | 0.01% |
1,729,253
+80,120
| +5% | +$1.87M |
|
|
CERN
825
DELISTED
Cerner Corp
CERN
| $44.9M | 0.01% |
766,517
+23,990
| +3% | +$1.34M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.